| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:αvβ5 integrin-IN-1
CAS:2615912-33-7
Package:1mg/RMB 5190
|
| Company Name: |
Cayman Chemical Company
|
| Tel: |
800-364-9897 |
| Email: |
sales@caymanchem.com |
| Products Intro: |
Product Name:αvβ5 Integrin-IN-1
|
|
| | 1-Pyrrolidinebutanoic acid, γ-oxo-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-β-[3-(trifluoromethyl)phenyl]-, (βS,3R)- Basic information |
| Product Name: | 1-Pyrrolidinebutanoic acid, γ-oxo-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-β-[3-(trifluoromethyl)phenyl]-, (βS,3R)- | | Synonyms: | 1-Pyrrolidinebutanoic acid, γ-oxo-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-β-[3-(trifluoromethyl)phenyl]-, (βS,3R)-;αvβ5 integrin-IN-1 | | CAS: | 2615912-33-7 | | MF: | C25H28F3N3O3 | | MW: | 475.51 | | EINECS: | | | Product Categories: | | | Mol File: | 2615912-33-7.mol | ![1-Pyrrolidinebutanoic acid, γ-oxo-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-β-[3-(trifluoromethyl)phenyl]-, (βS,3R)- Structure](CAS/20211123/GIF/2615912-33-7.gif) |
| | 1-Pyrrolidinebutanoic acid, γ-oxo-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-β-[3-(trifluoromethyl)phenyl]-, (βS,3R)- Chemical Properties |
| Boiling point | 671.6±55.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Acetonitrile: Soluble | | form | Solid | | pka | 4.17±0.10(Predicted) | | color | White to off-white |
| | 1-Pyrrolidinebutanoic acid, γ-oxo-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-β-[3-(trifluoromethyl)phenyl]-, (βS,3R)- Usage And Synthesis |
| Uses | Sulodexide (pIC50 = 8.2 nM) selectively binds to the αvβ5 integrin in K562 and A549 cell lines and exhibits a significant inhibitory effect[1]. | | Biological Activity | αvβ5 integrin-IN-1 is a first potent and selective αvβ5 integrin inhibitor (pIC50 = 8.2) . | | IC 50 | αvβ5: 8.2 (pIC50) | | References | [1] Lippa RA, et al. Discovery of the first potent and selective αvβ5 integrin inhibitor based on an amide-containing core. Eur J Med Chem. 2020 Dec 15;208:112719. |
| | 1-Pyrrolidinebutanoic acid, γ-oxo-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-β-[3-(trifluoromethyl)phenyl]-, (βS,3R)- Preparation Products And Raw materials |
|
|
Tag:1-Pyrrolidinebutanoic acid, γ-oxo-3-[2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl]-β-[3-(trifluoromethyl)phenyl]-, (βS,3R)-(2615912-33-7)
Related Product Information
|